 |
Ombitasvir/Paritaprevir/Ritonavir |
|---|---|
| Trade Name | Technivie� Tablets |
| Orphan Indication | Pediatric patients with chronic hepatitis C virus infection |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-24 00:00:00 |
| Sponsor | AbbVie Inc.;1 North Waukegan Road;North Chicago, Illinois, 60064 |
